IMMU - Immunomedics Inc.
Previous close
87.86
0 0%
Share volume: 0
Last Updated: Thu 22 Oct 2020 06:00:00 AM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$87.86
0.00
0.00%
Summary score
20%
Profitability
14%
Dept financing
50%
Liquidity
58%
Performance
10%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-38.69%
Return on assets
-18.71%
Return on sales
-4785.64%
Return on invested capital
328.34%
Total debt ratio
115.92%
Debt ratio change over timeo
-0.17%
Current Ratio
7.76%
Quick Ratio
3.72%
Cash Position Ratio
7.11%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-121.38%
Return on assets
-13.34%
Return on sales
-264.08%
Return on invested capital
262.79%
Total debt ratio
66.94%
Debt ratio change over timeo
-0.82%
Current Ratio
9.16%
Quick Ratio
12.58%
Cash Position Ratio
8.72%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-11.2%
Return on assets
-4.92%
Return on sales
-264.08%
Return on invested capital
139.61%
Total debt ratio
44.92%
Debt ratio change over time
-0.83%
Current Ratio
12.84%
Quick Ratio
12.58%
Cash Position Ratio
11.99%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.12%
Return on assets
-111.78%
Return on sales
-9881.88%
Return on invested capital
77.77%
Total debt ratio
-17.26%
Debt ratio change over time
-0.17%
Current Ratio
4.41%
Quick Ratio
1%
Cash Position Ratio
3.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | IMMU | MNTA | ONCE | THOR |
---|---|---|---|---|
Return on equity | -38.69% | -11.55% | -12.25% | 80.18% |
Return on assets | -18.71% | -9.1% | -9.49% | -16.7% |
Return on sales | -4785.64% | 0% | -349.39% | 0% |
Return on invested capital | 328.34% | -54.81% | -117.39% | 503.42% |
Profitability | 16% | 50% | 0% | 50% |
Total debt ratio | 115.92% | 25.21% | 26.21% | 26.3% |
Debt ratio change over time | -0.17% | -1.1% | -1.45% | -0.66% |
Dept financing | 50% | 5% | 6% | 6% |
Current Ratio | 9.16% | 6.1% | 4.67% | 18.87% |
Quick Ratio | 12.58% | 0% | 4.35% | 0% |
Cash Position Ratio | 8.72% | 2.86% | 2.07% | 2.22% |
Liquididy | 49% | 20% | 51% | 48% |
Short-term ratios | IMMU | MNTA | ONCE | THOR |
---|---|---|---|---|
Return on equity | -121.38% | -14.72% | -19.25% | -8.04% |
Return on assets | -13.34% | -11.86% | -9.76% | -8.05% |
Return on sales | -264.08% | 0% | -305.87% | 0% |
Return on invested capital | 262.79% | 517.6% | -49.24% | 520.72% |
Profitability | 13% | 50% | 0% | 75% |
Total debt ratio | 66.94% | 26.58% | 50.82% | 7.15% |
Debt ratio change over time | -0.82% | -1.16% | -2.24% | -0.98% |
Dept financing | 50% | 10% | 19% | 3% |
Current Ratio | 9.16% | 6.1% | 4.67% | 18.87% |
Quick Ratio | 12.58% | 0% | 4.35% | 0% |
Cash Position Ratio | 8.72% | 2.86% | 2.07% | 2.22% |
Liquididy | 62% | 16% | 21% | 31% |